Meridian Bioscience reported $-6681000 in Operating Profit for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Abbott ABT:US $ 2388M 524M
Accelerate Diagnostics AXDX:US -13249000 6.21M
Atrion ATRI:US 11.03M 3.19M
Becton, Dickinson and BDX:US $ 535M 117M
Bio Rad Laboratories BIO:US $ 120.22M 23.21M
Cerulean Pharma CERU:US $ -8400450 1.14M
Meridian Bioscience VIVO:US $ -6.68M 42.82M
Thermo Fisher Scientific TMO:US $ 2001M 820M
Trinity Biotech TRIB:US $ -10.1M 10.68M